Phibro Animal Health | PAHC - Loan Capital

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $603.6M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
ANI Pharmaceuticals USD 297.68M 310.67M Sep/2025
Assertio Holdings USD 39.17M 120K Sep/2025
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Canopy Growth CAD 226.33M 62.67M Sep/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Henry Schein USD 2.15B 63M Sep/2025
Idexx Laboratories USD 374.84M 17K Dec/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Merck USD 39.97B 6B Sep/2025
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Pacira USD 376.72M 1.37M Sep/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Zoetis USD 9.04B 1.97B Dec/2025